Scandinavian Medical Solutions A/S (SMSMED.CO)

DKK 5.6

(-4.44%)

EBITDA Summary of Scandinavian Medical Solutions A/S

  • Scandinavian Medical Solutions A/S's latest annual EBITDA in 2023 was 21.22 Million DKK , up 36.28% from previous year.
  • Scandinavian Medical Solutions A/S's latest quarterly EBITDA in 2024 Q2 was 4.02 Million DKK , down 0.0% from previous quarter.
  • Scandinavian Medical Solutions A/S reported an annual EBITDA of 15.57 Million DKK in 2022, up 40.31% from previous year.
  • Scandinavian Medical Solutions A/S reported an annual EBITDA of 11.1 Million DKK in 2021, up 81.38% from previous year.
  • Scandinavian Medical Solutions A/S reported a quarterly EBITDA of 4.02 Million DKK for 2024 Q1, down -36.4% from previous quarter.
  • Scandinavian Medical Solutions A/S reported a quarterly EBITDA of 6.64 Million DKK for 2023 Q4, up 100.0% from previous quarter.

Annual EBITDA Chart of Scandinavian Medical Solutions A/S (2023 - 2019)

Historical Annual EBITDA of Scandinavian Medical Solutions A/S (2023 - 2019)

Year EBITDA EBITDA Growth
2023 21.22 Million DKK 36.28%
2022 15.57 Million DKK 40.31%
2021 11.1 Million DKK 81.38%
2020 6.11 Million DKK 55.66%
2019 3.93 Million DKK 0.0%

Peer EBITDA Comparison of Scandinavian Medical Solutions A/S

Name EBITDA EBITDA Difference
Ambu A/S 691 Million DKK 96.928%
ChemoMetec A/S 193.97 Million DKK 89.058%
Demant A/S 5.21 Billion DKK 99.593%
GN Store Nord A/S 2.31 Billion DKK 99.082%
ViroGates A/S -12.48 Million DKK 270.062%